As­traZeneca's Pas­cal So­ri­ot picks up $21.5M pay pack­age in 2020, a big haul in year marked by Covid-19 shot de­vel­op­ment

As­traZeneca’s 2020 was one for the books as the British drug­mak­er kept up a fer­vid pace with part­ner Ox­ford Uni­ver­si­ty to de­vel­op their ade­n­ovirus-based Covid-19 shot. In the mean­time, sales growth in the US and emerg­ing mar­kets drove up As­traZeneca’s top line — and that proved lu­cra­tive for CEO Pas­cal So­ri­ot.

So­ri­ot bagged a 2020 com­pen­sa­tion pack­age worth $21.5 mil­lion in 2020, a slight in­crease from his 2019 to­tal de­spite As­traZeneca post­ing 10% rev­enue growth on the year, ac­cord­ing to the phar­ma gi­ant’s an­nu­al re­port.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER